calpain substrates
Recently Published Documents


TOTAL DOCUMENTS

13
(FIVE YEARS 0)

H-INDEX

9
(FIVE YEARS 0)

2013 ◽  
Vol 288 (51) ◽  
pp. 36717-36732 ◽  
Author(s):  
Chiho Kim ◽  
Nuri Yun ◽  
Young Mook Lee ◽  
Jae Y. Jeong ◽  
Jeong Y. Baek ◽  
...  

Molecules ◽  
2011 ◽  
Vol 16 (2) ◽  
pp. 1739-1748 ◽  
Author(s):  
Nora Caberoy ◽  
Gabriela Alvarado ◽  
Wei Li

2010 ◽  
Vol 88 (5) ◽  
pp. 584-594 ◽  
Author(s):  
James S.C. Gilchrist ◽  
Tom Cook ◽  
Bernard Abrenica ◽  
Babak Rashidkhani ◽  
Grant N. Pierce

We investigated calpain activation in the heart during ischemia–reperfusion (I–R) by immunologically mapping the fragmentation patterns of calpain and selected calpain substrates. Western blots showed the intact 78 kDa large subunit of membrane-associated calpain was autolytically fragmented to 56 and 43 kDa signature immunopeptides following I–R. Under these conditions, the 78 kDa calpain large subunit from crude cytosolic fractions was markedly less fragmented, with only weakly stained autolytic peptides detected at higher molecular weights (70 and 64 kDa). Western blots also showed corresponding calpain-like degradation products (150 and 145 kDa) of membrane-associated α-fodrin (240 kDa) following I–R, but in crude myofibrils α-fodrin degradation occurred in a manner uncharacteristic of calpain. For control hearts perfused in the absence of ischemia, autolytic fragmentation of calpain and calpain-like α-fodrin degradation were completely absent from most subcellular fractions. The exception was sarcolemma-enriched membranes, where significant calpain autolysis and calpain-like α-fodrin degradation were detected. In purified sarcoplasmic reticulum membranes, RyR2 and SERCA2 proteins were also highly degraded, but for RyR2 this did not occur in a manner characteristic of calpain. When I–R-treated hearts were perfused with peptidyl calpain inhibitors (ALLN or ALLM; 25 µmol/L), calpain autolysis and calpain-like degradation of α-fodrin were equally attenuated by each inhibitor. However, only ALLN protected against early loss of developed pressure in hearts following I–R, with no functionally protective effect of ALLM observed. Our studies suggest calpain is preferentially activated at membranes following I–R, possibly contributing to impaired ion channel function implicated by others in I–R injury.


2009 ◽  
Vol 481 (2) ◽  
pp. 219-225 ◽  
Author(s):  
Zoltan Bozoky ◽  
Anita Alexa ◽  
Julia Dancsok ◽  
Gergo Gogl ◽  
Eva Klement ◽  
...  
Keyword(s):  
S2 Cells ◽  

2007 ◽  
Vol 28 (4) ◽  
pp. 655-673 ◽  
Author(s):  
Matthew B Bevers ◽  
Robert W Neumar

The calpain family of proteases is causally linked to postischemic neurodegeneration. However, the precise mechanisms by which calpains contribute to postischemic neuronal death have not been fully elucidated. This review outlines the key features of the calpain system, and the evidence for its causal role in postischemic neuronal pathology. Furthermore, the consequences of specific calpain substrate cleavage at various subcellular locations are explored. Calpain substrates within synapses, plasma membrane, endoplasmic reticulum, lysosomes, mitochondria, and the nucleus, as well as the overall effect of postischemic calpain activity on calcium regulation and cell death signaling are considered. Finally, potential pathways for calpain-mediated neurodegeneration are outlined in an effort to guide future studies aimed at understanding the downstream pathology of postischemic calpain activity and identifying optimal therapeutic strategies.


2006 ◽  
Vol 291 (3) ◽  
pp. E544-E548 ◽  
Author(s):  
Kenichi Otani ◽  
Kenneth S. Polonsky ◽  
John O. Holloszy ◽  
Dong-Ho Han

It was previously found that transgenic mice that overexpress the calpain inhibitor calpastatin (CsTg) have an ∼3-fold increase in GLUT4 protein in their skeletal muscles. Despite the increase in GLUT4, which appears to be due to inhibition of its proteolysis by calpain, insulin-stimulated glucose transport is not increased in CsTg muscles. PKB (Akt) protein level is reduced ∼60% in CsTg muscles, suggesting a possible mechanism for the relative insulin resistance. Muscle contractions stimulate glucose transport by a mechanism that is independent of insulin signaling. The purpose of this study was to test the hypothesis that the threefold increase in GLUT4 in CsTg would result in a large increase in contraction-stimulated glucose transport. CAMKII and AMPK mediate steps in the contraction-stimulated pathway. The protein levels of AMPK and CAMKII were increased three- to fourfold in CsTg muscles, suggesting that these proteins are also calpain substrates. Despite the large increases in GLUT4, AMPK, and CAMKII, contraction-stimulated GLUT4 translocation and glucose transport were not increased above wild-type values. These findings suggest that inhibition of calpain results in impairment of a step in the GLUT4 translocation process downstream of the insulin- and contraction-signaling pathways. They also provide evidence that CAMKII and AMPK are calpain substrates.


2001 ◽  
Vol 21 (6) ◽  
pp. 2213-2220 ◽  
Author(s):  
Mohammad Azam ◽  
Shaida S. Andrabi ◽  
Kenneth E. Sahr ◽  
Lakshmi Kamath ◽  
Athan Kuliopulos ◽  
...  

ABSTRACT Conventional calpains are ubiquitous calcium-regulated cysteine proteases that have been implicated in cytoskeletal organization, cell proliferation, apoptosis, cell motility, and hemostasis. There are two forms of conventional calpains: the μ-calpain, or calpain I, which requires micromolar calcium for half-maximal activation, and the m-calpain, or calpain II, which functions at millimolar calcium concentrations. We evaluated the functional role of the 80-kDa catalytic subunit of μ-calpain by genetic inactivation using homologous recombination in embryonic stem cells. The μ-calpain-deficient mice are viable and fertile. The complete deficiency of μ-calpain causes significant reduction in platelet aggregation and clot retraction but surprisingly the mutant mice display normal bleeding times. No detectable differences were observed in the cleavage pattern and kinetics of calpain substrates such as the β3 subunit of αIIbβ3 integrin, talin, and ABP-280 (filamin). However, μ-calpain null platelets exhibit impaired tyrosine phosphorylation of several proteins including the β3 subunit of αIIbβ3 integrin, correlating with the agonist-induced reduction in platelet aggregation. These results provide the first direct evidence that μ-calpain is essential for normal platelet function, not by affecting the cleavage of cytoskeletal proteins but by potentially regulating the state of tyrosine phosphorylation of the platelet proteins.


1999 ◽  
Vol 263 (1) ◽  
pp. 94-99 ◽  
Author(s):  
Kim M. McGinnis ◽  
Margaret E. Gnegy ◽  
Yang Hae Park ◽  
Neeta Mukerjee ◽  
Kevin K.W. Wang
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document